Progressive Care, Inc.
RXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $13 | $15 | $14 | $12 |
| % Growth | -7.9% | 1.4% | 16.7% | – |
| Cost of Goods Sold | $12 | $14 | $13 | $9 |
| Gross Profit | $2 | $1 | $2 | $4 |
| % Margin | 12.9% | 7.3% | 12.5% | 30.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $3 | $4 |
| SG&A Expenses | $1 | $3 | $1 | $4 |
| Sales & Mktg Exp. | $1 | $0 | -$2 | $0 |
| Other Operating Expenses | $0 | -$3 | $0 | $3 |
| Operating Expenses | $1 | $1 | $1 | $5 |
| Operating Income | $0 | -$0 | $1 | -$1 |
| % Margin | 3.7% | -1.8% | 4.1% | -11% |
| Other Income/Exp. Net | -$10 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$9 | -$0 | -$13 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$0 | -$13 | -$1 |
| % Margin | -68.8% | -2.5% | -92% | -11.1% |
| EPS | -1.49 | -0.06 | -2.13 | -0.22 |
| % Growth | -2,400% | 97.2% | -868.2% | – |
| EPS Diluted | -1.49 | -0.06 | -2.13 | -0.22 |
| Weighted Avg Shares Out | 6 | 6 | 6 | 6 |
| Weighted Avg Shares Out Dil | 6 | 6 | 6 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$8 | $0 | -$15 | -$1 |
| % Margin | -62.9% | 3.2% | -101.1% | -4.8% |